Home › Funds › Catalio Capital Management, LP › AMLX
Catalio Capital Management, LP position in AMLX
AMYLYX PHARMACEUTICALS INC · Health Care
Catalio Capital Management, LP reported holding 505,882 shares of AMLX (AMYLYX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$14.7M, representing 2.75% of its reported portfolio and ranking #15 among its reported holdings. Catalio Capital Management, LP first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Catalio Capital Management, LP's AMLX position evolved
Catalio Capital Management, LP first disclosed a stake in AMLX in Q3 2026 at 505,882 shares (US$14.7M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 505.88K | $14.72M | New |
About AMLX and 13F data
AMLX (AMYLYX PHARMACEUTICALS INC) is a Health Care company. 53 other funds we track also report a position in AMLX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$307.7M), TCG Crossover Management, LLC (US$181.7M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$158.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AMLX
- PERCEPTIVE ADVISORS LLC 10.57M sh · $307.70M · Q3 2026
- TCG Crossover Management, LLC 6.24M sh · $181.69M · Q3 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 5.43M sh · $157.97M · Q3 2026
- Saturn V Capital Management LP 4.47M sh · $130.12M · Q3 2026
- RA CAPITAL MANAGEMENT, L.P. 4.28M sh · $124.53M · Q3 2026
- First Light Asset Management, LLC 3.99M sh · $116.01M · Q3 2026
- Siren, L.L.C. 2.48M sh · $72.19M · Q3 2026
- Commodore Capital LP 2.00M sh · $58.20M · Q3 2026
- Elmind Capital, LP 894.76K sh · $26.04M · Q3 2026
- Boxer Capital Management, LLC 893.15K sh · $25.99M · Q3 2026
- Rock Springs Capital Management LP 756.77K sh · $22.02M · Q3 2026
- GREAT POINT PARTNERS LLC 700.00K sh · $20.37M · Q3 2026
More on Catalio Capital Management, LP
FAQ
How long has Catalio Capital Management, LP held AMLX?
Catalio Capital Management, LP has disclosed AMLX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Catalio Capital Management, LP's current position in AMLX?
As of Q3 2026, Catalio Capital Management, LP holds 505.88K shares of AMLX (AMYLYX PHARMACEUTICALS INC), valued at $14.72M, representing 2.75% of its reported portfolio and ranking #15.
Has Catalio Capital Management, LP been buying or selling AMLX?
In the latest 13F filing (Q3 2026), Catalio Capital Management, LP newly opened its position in AMLX.
Which other funds hold AMLX?
Other major institutional holders of AMLX include PERCEPTIVE ADVISORS LLC, TCG Crossover Management, LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, among 53 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.